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Human exposure to lead continues to be a
serious public health problem (1). Although
blood lead levels continue to decline in the
U.S. population, specific population groups
are disproportionately at high risk for lead
exposure. In a recent survey conducted by the
National Center for Environmental Health
and the Centers for Disease Control and
Prevention (CDC), 4.4% of the children sur-
veyed had blood lead levels of at least 10
µg/dL (1). These results emphasized the
importance of leaded paint in older homes as
a continuing exposure source (1). Other
exposure sources include lead in the work-
place, in dust and soil, in folk remedies, in
crystal or ceramic containers, and in hobby-
related materials (1,2).
Lead exposure is associated with neurologic
(3–6), growth (3,7), and reproductive defects
(7–25). Lead exposure in men has been associ-
ated with abnormalities of spermatogenesis
(9,11–13). An inverse relationship between
blood lead and sperm concentration has been
reported (14,15). Animal studies tend to sup-
port the conclusion that lead exposure dis-
rupts the reproductive hormones, but clinical
studies evaluating the relationship between
lead exposure and reproductive hormone
changes are inconclusive (8,11).
The reproductive axis is composed
anatomically of the hypothalamus, pituitary,
and testes in males and physiologically by
gonadotropin-releasing hormone (GnRH),
luteinizing hormone (LH), follicle-stimulating
hormone (FSH), testosterone, and inhibin
(18). GnRH, a peptide hormone, is produced
in the medial basal portion of the hypothala-
mus. GnRH stimulates the pituitary gland to
produce and secrete LH and FSH. LH is pri-
marily responsible for stimulating testicular
Leydig cell secretion of testosterone. FSH acts
on the Sertoli cells of the testes to stimulate
spermatogenesis and inhibin.
In the animal model, lead has a primary
toxic affect on the hypothalamic–pituitary
unit, a primary effect on the testes, and acts at
all levels of the reproductive axis. We and
others have demonstrated, using the rat
model, that lead exposure produces a
dose–response suppression of serum testos-
terone and spermatogenesis accompanied by
no significant changes in circulating
gonadotropin levels (16,17). However,
mRNA levels of GnRH in the hypothalamus
and LH in the pituitary are increased with
lead exposure (17–20). This reported
endocrine disruption was noted at blood lead
levels > 30 µg/dL after exposure times of 2–8
weeks. Limited data are available on the toxic
effects of lead at lower exposure concentra-
tions and for longer periods of exposure (21).
Increasing the length of exposure to 8 weeks
seems to allow the adult animal to normalize
its responses (22). Other data suggest that the
lead-exposed animal is able to adapt to the
metal’s toxic effects (20,22–25).
We are investigating the molecular mecha-
nism(s) by which lead disrupts the reproductive
axis. We reported previously that exposure to
lead acetate in relatively high dose ranges for
3 weeks increased mRNA levels of GnRH
and LH as well as stored levels of LH (19).
Consistent with the conclusion that the
reproductive axis adapts to the toxic effects of
lead was the finding that the increase in
GnRH, mRNA, and β-LH concentration
plateaued once the animal’s blood lead levels
reached 50 µg/dL.
The current study was designed to deter-
mine whether exposure to lower levels of lead
acetate over a longer time would produce a
similar pattern of adaption to toxicity at the
molecular level in the male rat, and whether
changes in GnRH mRNA are mirrored by
changes in circulating levels of GnRH.
Materials and Methods
Adult male Sprague-Dawley rats, 92 days of
age upon arrival at the laboratory, were pur-
chased from Charles River Laboratories
(Portage, MI) and housed for 8 days before
being randomly distributed into study groups
of 12–16 rats. The rats were housed in poly-
carbonate cages suspended on stainless-steel
racks in a room with a 12 hr:12 hr light:dark
cycle and controlled temperature. Animals
were allowed free access to lead-free Purina
(Ralston-Purina, St. Louis, MO) laboratory
chow and were maintained in accordance
with the standards set forth in the Animal
Welfare Act. Acid-washed amber-glass water
bottles, equipped with neoprene stoppers
containing stainless dipper tubes with ball
bearings, were used to dispense deionized
water containing either no lead acetate
(PbAc) or 0.025, 0.05, 0.1, 0.3% PbAc
(Fisher Scientiﬁc, Springﬁeld, NJ). We added
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Lead is a male reproductive toxicant. Data suggest that rats dosed with relatively high levels of
lead acetate for short periods of time induced changes in the hypothalamic gonadotropin-releasing
hormone (GnRH) at the molecular level, but these changes were attenuated with increased con-
centration of exposure. The current study evaluated whether exposure to low levels of lead acetate
over longer periods of time would produce a similar pattern of adaptation to toxicity at the molec-
ular and biologic levels. Adult 100-day-old Sprague-Dawley male rats were dosed with 0, 0.025,
0.05, 0.1, and 0.3% lead acetate in water. Animals were killed after 1, 4, 8, and 16 weeks of treat-
ment. Luteinzing hormone (LH) and GnRH levels were measured in serum, and lead levels were
quantiﬁed in whole blood. Hypothalamic GnRH mRNA levels were also quantiﬁed. We found no
signiﬁcant differences in serum LH and GnRH among the groups of animals treated within each
time period. A signiﬁcant dose-related increase of GnRH mRNA concentrations with lead dosing
occurred in animals treated for 1 week. Animals treated for more than 1 week also exhibited a sig-
niﬁcant increase in GnRH mRNA, but with an attenuation of the increase at the higher concen-
trations of lead with increased duration of exposure. We conclude that the signals within and
between the hypothalamus and pituitary gland appear to be disrupted by long-term, low-dose lead
exposure. Key words: gonadotropin-releasing hormone, hypothalamic–pituitary axis, lead acetate.
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controls) to preclude precipitation of insolu-
ble PbAc salts. We selected the doses of lead
on the basis of previously published studies
(19,22). Animals were weighed, and the vol-
ume of water consumption was measured at
the beginning of study weeks 1, 4, 8, and 16.
The animals were killed by decapitation
after 1, 4, 8, or 16 weeks of treatment.
Hypothalami were dissected and snap frozen
in liquid nitrogen and stored at –70°C until
processing for RNA and DNA studies. Trunk
blood was collected and lead levels measured.
Serum was separated and frozen for the mea-
surement of GnRH and LH levels. Care and
treatment of animals was conducted in accor-
dance with established guidelines and approval
of the University of Southern California
Animal Use Committee and internal review
board. 
Measurement of blood lead and hormones.
Lead analysis was performed by the Air and
Industrial Hygiene Laboratory of the
California Department of Health Services as
described previously (26).
We used the ultra-sensitive DELFIA rat
LH assay (Wallac Oy, Turku, Finland) to
measure LH in rodent serum (27). Sensitivity
was 0.03 ng/mL, and the intra- and interassay
coefﬁcients of variations at 33.1 ng/mL were
3.4% and 16.0%, respectively.
We determined the GnRH concentrations
in plasma by radioimmunoassay using reagents
(125I-labeled GnRH and GnRH standards and
antiserum) from Phoenix Pharmaceuticals,
Inc. (Mountain View, CA). The kit standard
was compared to a standard curve generated
using GnRH peptide supplied by the National
Institute of Diabetes and Digestive and Kidney
Diseases (National Institutes of Health,
Bethesda, MD). Plasma was extracted using
acetic acid and Bond Elut LRC-C18 columns
(Varian, Harbor City, CA). Intra- and interas-
say variations were 10% and 18%, respec-
tively. Sensitivity of the assay was 0.1 pg/mL.
Preparation of RNA and DNA. Total
RNAs were extracted from frozen hypothalami
(n = 3 per treatment group) by homogenization
in guanidium isothiocyanate according to
established protocols (28). The concentrations
of purified RNA and DNA product were
determined by optical density at wavelength
260 nm (Beckman DU 640, Columbia, MO).
Northern blot performance. Isolated total
RNA (30 µg per lane) was electrophoresed
separately using formaldehyde 1.2% agarose
gels in MOPS buffer and transferred via cap-
illary action onto Nylon membranes (MSI,
Westboro, MA).
An EcoR1/Hind III fragment (0.396 kb)
of the rat GnRH cDNA insert and an
EcoR1/Hind III fragment (0.7 kb) of the rat
β-actin cDNA insert were excised and puri-
fied through a 1% Sea Plaque low melting
agarose (FMC BioProducts, Rockland, ME).
Both cDNA fragments as probes were labeled
with [α-32P]-dCTP (NEN Life Science
Products, Inc., Boston, MA) using a random
primer labeling kit (Life Technologies,
Bethesda, MD). (The cDNA probe was sup-
plied by J. L. Robertson, Mount Sinai School
of Medicine, New York.)
Hybridization of blots with a 32P-GnRH
probe was performed in a NaPO4 buffer with
7% SDS, 1 mM EDTA, and 1 mg/mL
bovine serum albumin at 68°C for 18–20 hr.
Blots were washed in 1% SDS, 50 mM
NaCl, 1 mM EDTA, and exposed to X-ray
film at –70°C with intensifying screen for
about 4–5 days. We confirmed equivalent
RNA loading by rehybridization of the blots
for the β-actin probe as an internal standard.
Densitometric analysis. We analyzed
autoradiograms for the relative intensity of
signals by densitometry (BioRad Imaging
Densitometer GS-670) using BioRad
Molecular Analyst PC Version 1-1 (Life
Sciences Group, Hercules, CA).
Statistical analysis. We analyzed mean
data by analysis of variance and performed
post-hoc comparisons with the Newman-
Keuls test. Pearson’s correlation coefficient
was used to evaluate the linear relationship
between lead levels and the amount of GnRH
transcripts. Significance level was p < 0.05.
Values are means ± SEM. We analyzed data
using the commercially available software
package SPSS (SPSS, Inc., Chicago, IL).
Results
Body weights and water consumption.
Although there was a trend toward lower
body weights with higher doses of lead in the
animals treated for 8 and 16 weeks, rare sig-
nificant differences in body weights at the
time of sacriﬁce between lead-treated animals
and their respective control groups were
observed in any experimental group (Table
1). All lead-treated animals consumed less
water than did their respective controls (p <
0.001; Table 1).
Circulating lead, GnRH, and LH levels.
All control animals had mean blood lead lev-
els consistently < 3 µg/mL. All lead-treated
animals had blood lead levels greater than
those of controls (p < 0.001; Table 2).
No significant differences in plasma
GnRH and LH were found among animals
treated with increasing doses of lead acetate
for any time period studied (Table 2).
Northern blot analysis. A significant,
steady dose–response increase of GnRH
mRNA concentrations with lead dosing was
seen in animals treated for 1 week (p < 0.01;
Figure 1). Animals treated for more than 1
week also exhibited a significant increase in
GnRH mRNA, but with an attenuation of
the increase at the higher concentrations of
lead with increased duration of exposure
(Figure 2). Correction of loading by use of
the standard probe β-actin indicated that the
concentrations of GnRH mRNA were not
dependent on the amount of RNA loaded per
lane (Figure 2). Correlation between lead
blood levels and expression of mRNA GnRH
levels for doses ranging from 0 to 0.1% was
signiﬁcant (r = 0.9, p < 0.05).
Discussion
The data presented here show that low doses
of lead for long periods of time alter the rat
hypothalamic–pituitary axis in a manner
similar to that previously reported at higher
doses for shorter periods of time. These
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Table 1. Water consumption and body weights in control and lead-exposed male rats (mean ± SEM; n = 10–16).
Weeks of Percent PbAc in water
exposure Measurement 0 0.025 0.05 0.1 0.3 p-Value
1 Water consumption 41.21 ± 0.77 37.12 ± 0.86* 37.80 ± 0.89* 32.81 ± 0.63* 27.80 ± 0.49* 0.001
(g/animal/day)
Weight (g) 408 ± 2 403 ± 2 401 ± 2 401 ± 1.8* 404 ± 1.7 0.109
4 Water consumption 43.14 ± 0.97 37.18 ± 1.10* 37.38 ± 1.17* 34.90 ± 0.84* 28.89 ± 0.51* 0.001
(g/animal/day)
Weight (g) 501 ± 4 493 ± 5 490 ± 3 489 ± 4 487 ± 3* 0.015
8 Water consumption 40.34 ± 1.02 36.24 ± 1.39* 37.65 ± 1.05* 35.19 ± 1.04* 30.96 ± 0.49* 0.001
(g/animal/day)
Weight (g) 578 ± 7 572 ± 8 566 ± 6 564 ± 7 559 ± 5 0.052
16 Water consumption 37.91 ± 1.52 33.76 ± 1.39* 33.48 ± 1.69* 33.04 ± 1.10* 27.58 ± 0.68* 0.001
(g/animal/day)
Weight (g) 694 ± 11 680 ± 15 668 ± 11 672 ± 13 661 ± 9 0.083
*p < 0.05.results agree with previous ﬁndings that indi-
cated a significant positive correlation
between lead dose and expression of mRNA
GnRH levels in the hypothalamus (17,19).
Furthermore, the data support the hypothesis
that lead exposure initially induces an
increase in intracellular levels of GnRH
mRNA in a dose-related manner, but with an
attenuation in message production at higher
levels of blood lead. The attenuation of the
increase in GnRH mRNA levels with a
greater dose of lead exposure without a signif-
icant change in the levels of plasma GnRH
and LH support the conclusion that the male
Sprague-Dawley rat adapts to the toxic effects
of lead on the hypothalamus and that alter-
ations in GnRH production at the molecular
level do not translate to increases in circulat-
ing GnRH or LH levels.
Previous published studies in other sys-
tems support the hypothesis that adaptation
to lead toxicity occurs with prolonged expo-
sure. Increased duration of exposure to lead
does not produce more profound toxic effects
on circulating testosterone, sperm concentra-
tion, and sperm production rate in animals
whose dosing began at the beginning of the
pubertal period (22). Castrated, lead-treated
male rats are able to respond to castration
with an increase in LH, indicating an adapta-
tion of the hypothalamic–pituitary axis to the
toxic effects of lead (23). At lower exposure
levels, a significant disruption in the repro-
ductive axis occurs at puberty in pups
exposed from gestation through the onset of
puberty (9,20,29) or in adulthood after expo-
sure during sexual differentiation (30).
However, animals whose exposure continues
to adulthood do not manifest as profound an
alteration in the hypothalamic–pituitary–
gonadal axis (20). Studies in monkeys also
suggest that chronically exposed animals may
develop compensatory mechanisms. In the
female monkey, lead exposure during adult-
hood induced menstrual irregularities (31),
but chronic dosing from infancy throughout
adulthood did not alter menstrual cycles (32).
Chronically lead-exposed male monkeys
revealed only subtle signs of reproductive
toxicity (24).
A similar tolerance has been reported in
studies evaluating the renal toxicity of lead.
Hitzﬁeld and Taylor (33) reported the devel-
opment of resistance to lead in a rat kidney
cell line. Kidney cells pre-exposed to lead
showed a higher rate of protein synthesis than
nonadapted cells. They suggested that changes
in protein synthesis after lead exposure
appeared to be a potent parameter in the
development of this resistance. Clinical studies
also suggest an adaptation to lead’s toxic
effects on the kidney (34). However, clinical
studies evaluating the relationship between
duration of exposure and reproductive toxicity
have not been published.
Although lead exposure alters the produc-
tion of GnRH in the hypothalamus at the
molecular level, circulating GnRH and LH
levels are not altered significantly. Previous
studies evaluating higher exposure levels for
shorter periods of time reported similar
results (19,20,24,35). The signals within and
between the hypothalamus and pituitary
gland appear to be disrupted by lead expo-
sure, but elevations of GnRH mRNA levels
do not automatically translate into increased
blood levels of GnRH, at least in the lead-
intoxicated rat. GnRH is secreted from the
hypothalamus in a pulsatile fashion and in
turn stimulates LH biosynthesis and secretion
(36). Our failure to document a correspond-
ing change in serum GnRH levels may be due
to the fact that we measured only one serum
sample at the time of sacrifice. However, a
more likely explanation is that lead interferes
with the release of GnRH from the nerve ter-
minal in the median eminence. Auto-
radiographic studies indicated that 210Pb
accumulated in the greatest concentration in
the median eminence (37). Bratton and co-
workers (38) investigated the effects of lead
on norepinephrine and prostaglandin E2
(PGE2)-induced GnRH release from the
adult male rat median eminence incubated in
vitro. Lead did not alter basal GnRH release,
but it did block norepinephrine-induced
GnRH release in a dose-related manner.
Conversely, lead had no effect on the PGE2-
induced release of GnRH, but did block the
norepinephrine-stimulated release of PGE2.
Therefore, lead may disrupt GnRH release at
the hypothalamic level by interfering with
PGE2 synthesis or release. In vivo studies eval-
uating the effects of lead exposure on nora-
drenergic stimulation of GnRH release
support this conclusion. Lead exposure at high
doses interferes with naloxone-mediated
release of LH (18) and acts synergistically to
inhibit catecholamine synthesis by the tyro-
sine hydroxylase inhibitor α-methyl-p-tyro-
sine (23). Because the hypothalamic–pituitary
axis is a dynamic system and the actions of
lead at these central nervous system sites are
not completely suppressive (23), adequate
amounts of GnRH are released to maintain
LH synthesis and secretion resulting in steady-
state serum levels. As exposure time increases,
adaptation at the molecular level intensiﬁes.
These findings of perturbed GnRH
mRNA expression at low levels of lead expo-
sure are of potential clinical importance. The
CDC deﬁnes blood lead levels as elevated in
children if they exceed 10 µg/dL (1). Cognitive
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Table 2. Blood lead and serum GnRH and LH levels in control and lead-exposed male rats (mean ± SEM).
Weeks of Percent PbAc in water
exposure Measurementa 0.0 0.025 0.05 0.1 0.3 p-Value
1 Lead (µg/dL) < 2 12 ± 2* 17 ± 2* 20 ± 1* 28 + 1* 0.001
LH (ng/mL) 0.60 ± 0.09 0.96 ± 0.23 0.73 ± 0.13 0.56 ± 0.13 0.77 ± 0.24 0.143
GnRH (pg/mL) 20 ± 4 14 ± 1 16 ± 2 15 ± 1 13 ± 1 0.095
4 Lead (µg/dL) < 2 10 ± 1* 15 ± 1* 23 ± 2* 35 ± 4* 0.001
LH (ng/mL) 0.86 ± 0.19 1.09 ± 0.24 0.80 ± 0.12 0.96 ± 0.15 0.65 ± 0.11 0.273
GnRH (pg/mL) 14 ± 1 16 ± 1 15 ± 1 14 ± 2 14 ± 1 0.807
8 Lead (µg/dL) < 3 14 ± 2* 17 ± 2* 24 ± 1* 37 + 2* 0.001
LH (ng/mL) 0.70 ± 0.12 0.77 ± 0.12 0.41 ± 0.09 0.48 ± 0.05 0.57 ± 0.1 0.083
GnRH (pg/mL) 19 ± 1 16 ± 2 16 ± 1 16 ± 1 15 ± 1 0.436
16 Lead (µg/dL) < 3 12 ± 1* 18 ± 2* 27 ± 1* 42 ± 3* 0.001
LH (ng/mL) 0.87 ± 0.14 0.75 ± 0.12 0.65 ± 0.09 0.68 ± 0.06 0.63 ± 0.09 0.466
GnRH (pg/mL) 20 ± 1 16 ± 1 19 ± 1 15 ± 1 17 ± 1 0.071
aFor blood lead measurements, n = 10–16; for LH, n = 14–16; for GnRH, n = 7–12, except week 1 and week 16 at 0%, n = 5.
*p < 0.001.
Figure 1. Example of a northern blot for the quan-
tification of hypothalamic GnRH mRNA levels in
control and lead-dosed animals. Autoradiograms
depict GnRH mRNA levels in the medial basal
hypothalami of rats exposed to 0, 0.025, 0.05, 0.1,
and 0.3% PbAc for 1 week (p < 0.01). The data are
representative of 3 different northern blots on sep-
arate RNA samples collected for each lead dose.
β-actin
GnRH
0.000 0.025 0.050 0.100 0.300 PbAc (%)
Figure 2. Summary of GnRH β-actin mean density
ratios in control and lead-dosed animals over time.
Data represent the mean ± SEM for three hypothal-
ami per dose group per time point. 
*p < 0.01 as compared to controls.
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0.30and behavioral development may be altered in
children exposed to these low levels of lead
(4,5,21). We report lead-induced reproductive
abnormalities in male rats at lead levels as low
as 10 µg/dL. A recent clinical study evaluating
the impact of lead exposure on normal repro-
ductive development suggests that boys with
marginally increased blood lead levels may
mature sexually at a later age and have smaller
testicular volume than control subjects (39).
The exact mechanism by which this occurs
clinically remains to be elucidated, but our
results using an animal model suggest that sub-
tle disruptions in GnRH production and/or
release may be involved.
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